黑色素瘤特异性抗原在肿瘤中的表达及其对免疫治疗的作用
摘要
黑色素瘤特异性抗原（preferentially expressed antigen of melanoma,PRAME）是肿瘤睾丸抗原家族的一员,最初在黑色素瘤患者中被发现,是一种能够被细胞毒性T淋巴细胞特异性识别并引起肿瘤溶解的表面抗原[1],其表达可受调控区域的甲基化调节[2]。
出处
《武警医学》
CAS
2016年第1期92-96,共5页
Medical Journal of the Chinese People's Armed Police Force
二级参考文献12
-
1Ikeda H, Leth6 B, Lehmann F, et al. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss CTL ex- pressing an NIL inhibitory receptor[J]. Immtmity, 1997, 6(2): 199-208.
-
2Matsushita M, Ikeda H, Kizaid M, et al, Oantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukemia[J]. BrJ haematol, 2001, 112(4): 916-926.
-
3Gure AO, Stockert E, Arden KC, et al. CT10: a new cancer-tes tis(CT) antigen homologous to CT17 and the MACE family, identi fled by representational-difference analysis. Int J Cancer, 2000 85(5): 726-732.
-
4Paydas R, Tanriverdi K, Yavuz S, et al. PRAME mRNA Levels in cases with acute leukemia: clinical importance and future prospects [J]. AmJ Hematol, 2005, 79(4): 257-261.
-
5van Baren N, Chambost H, Ferrant A, et al. PRAME, a gene encod- ing an antigen recognized on a human melanoma by cytolytic T ceils is expressed in acute leukaemica cells[J]. BrJ Haematol, 1998, 102(5): 1376-1379.
-
6Steinbach D, HemannJ, Viehmaml S, et al. Clinical implications of PRAME gene expression in childhood acute myeloid leukemia . Cancer Genet Cytogenet, 2002, 133 (2) : 118-123.
-
7Pin Y, Zhu H, Jiang B, et al. Expression patterns of WT1 and PRAME in acute myeloid Leukemia patients and their usefulness for monitoring minimal residual disease[J]. Leuk Res, 2009, 33(3): 384-390.
-
8Oehler VG, Guthrie KA, Cummings CL, et al. The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differen- tiation in normal hematopoietic and leukemic progenitor cells[J]. Blood, 2009, 114(15): 3299-3308.
-
9Gostessi A, Mahrour N, Tijchon E, et al. The tumor antigen PRAME is a subunit of a Cul2 ubiquitin ligase and associates with active NFY promoters[I]. EMBOJ, 2011, 30 (18) : 3786-3798.
-
10Oehler VG, Guthrie KA, Cummings CL, et al. The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differen- tiation in normal hematopoietic and leukemic progenitor cells[J]. Blood, 2009, 114(15): 3299-3308.
-
1丁凯,王晓明,付蓉,阮二宝,刘惠,邵宗鸿.PRAME基因在急性白血病中的表达及意义[J].中国肿瘤临床,2012,29(9):551-554. 被引量：3
-
2刘召云.Prame 基因在血液恶性肿瘤中的表达与治疗[J].国际肿瘤学杂志,2014,41(8):611-614.
-
3聂莹(综述),潘凯丽(审校).PRAME在儿童急性白血病诊疗中的研究进展[J].国际儿科学杂志,2010,37(4):352-354.
-
4周培一,李维佳,魏彩霞,周挚.PRAME基因在成人急性白血病的表达及其与预后的相关性[J].中国实验血液学杂志,2007,15(6):1177-1181. 被引量：3
-
5徐凯红,张怡,欧阳桂芳.PRAME基因与肿瘤的研究[J].现代实用医学,2010,22(5):599-600.
-
6陈燕,唐爱发.肿瘤睾丸抗原PRAMEF12在肾细胞癌的表达研究[J].中国男科学杂志,2016,30(5):19-23.
-
7马鸣,焦文静,张金艳.NY-ESO-1在肿瘤中的表达及其临床意义研究进展[J].国际检验医学杂志,2015,36(21):3138-3141. 被引量：4
-
8周培一,李维佳.黑色素瘤特异性抗原基因与血液恶性肿瘤[J].癌变．畸变．突变,2005,17(4):254-256.
-
9范小菊,李慧慧,梁昌达,汤爱萍,费妍.PRAME与WT1基因在急性白血病患者中的表达及临床意义[J].江西医学院学报,2008,48(1):46-49. 被引量：3
-
10姜家豫,杨顺娥,徐继鸿,单利.急性肿瘤溶解综合征[J].新疆医学院学报,1993,16(1):36-40.
